VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma.
Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma. J Immunother. 2010 Apr; 33(3):316-25.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Biomarkers, Tumor
Cohort Studies
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Humans
Immunohistochemistry
Integrin alphaVbeta3
Ki-67 Antigen
Male
Melanoma
Middle Aged
Neoplasm Metastasis
Survival Analysis
Tachycardia
Time Factors
Treatment Outcome
Vascular Endothelial Growth Factor A
authors with profiles
JOHN KIRKWOOD